Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report) shares passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.28 and traded as low as $0.24. Northwest Biotherapeutics shares last traded at $0.24, with a volume of 2,251,472 shares trading hands.
Northwest Biotherapeutics Stock Up 0.4 %
The stock’s 50-day moving average is $0.27 and its 200 day moving average is $0.28. The stock has a market capitalization of $333.83 million, a PE ratio of -3.05 and a beta of -0.52.
About Northwest Biotherapeutics
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Read More
- Five stocks we like better than Northwest Biotherapeutics
- Stock Market Sectors: What Are They and How Many Are There?
- Ignore Reports, Apple Won’t Install Starlink with iOS 18.3
- ETF Screener: Uses and Step-by-Step Guide
- Casey’s Uptrend Remains Strong—New Highs on the Horizon
- What Do S&P 500 Stocks Tell Investors About the Market?
- Taiwan Semiconductor’s Huge U.S. Move—Stock Impact Ahead
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
